Download App

Log in to access Online Inquiry
Company Overview More
Suzhou Beikang Medical Co., Ltd. (formerly known as Jiangsu double Helix Biotechnology Co., Ltd.) is a Chinese investment holding company that mainly provides assisted reproductive gene testing solutions. The company provides genetic testing solutions and sells genetic testing equipment and instruments. Genetic testing solutions include the sale of testing kits and the provision of testing services. The company's main products include PGT-A kits. The company mainly does business in the domestic market.
CEO: Bo Liang
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

02170 BASECARE-B
3.800+0.250+7.04%
YOY
Do not show
Hide blank lines
(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(Q9)2020/09/30
Assets
Current assets
Inventory
425.86% 33.31M 9.25% 11.87M -46.03% 6.33M -- 8.61M
Accounts receivable
43.17% 125.25M 21.5% 112.68M 95.02% 87.48M -- 92.52M
Cash and equivalents
692.01% 1.52B 4797.09% 1.69B 696.2% 192.32M -- 225.41M
Secured deposit
-- 15.73M -- -- -- -- -- --
Other current assets
-78.5% 5.21M 2372.73% 816K 1053.35% 24.26M -- 14.44M
Total current assets
448.56% 1.7B 1212.23% 1.81B 170.05% 310.39M -- 340.98M
Non-current assets
Property, plant and equipment
123.65% 41.64M 21.02% 20.55M -14.5% 18.62M -- 17.27M
Deferred tax assets
-92.37% 1.52M 2.64% 15.15M 59.38% 19.85M -- 16.72M
Other illiquid assets
-- 42.48M -- -- -- -- -- --
Special items of non-current assets
772.43% 12.56M 449.79% 13.06M -26.49% 1.44M -- 1.86M
Total non-current assets
146.07% 98.2M 42.93% 48.76M 10.27% 39.91M -- 35.85M
Total assets
414.1% 1.8B 980.63% 1.86B 131.79% 350.3M -- 376.83M
Liabilities
Current liabilities
Accounts payable
-0.56% 37.28M -7.48% 26.95M 81.38% 37.49M -- 37.92M
Bank loans and overdrafts
-33.33% 20M -33.33% 20M 0% 30M -- 30M
Financial lease liabilities-current liabilities
343.17% 3.05M 92.56% 2.56M -53.83% 688K -- 944K
Total current liabilities
-11.51% 60.33M -18.25% 49.51M 30.71% 68.18M -- 68.87M
Net current assets
578.07% 1.64B 2173.03% 1.76B 285.81% 242.21M -- 272.11M
Total assets less current liabilities
516.96% 1.74B 1522.33% 1.81B 185.06% 282.12M -- 307.96M
Non-current liabilities
Long-term bank loan
-- 23.65M -- -- -- -- -- --
Financial lease liabilities-non-current liabilities
139.69% 1.87M 139.18% 2.7M -30.14% 781K -- 956K
Total non-current liabilities
3167.22% 25.52M -99.86% 2.7M -99.93% 781K -- 956K
Total liabilities
24.49% 85.85M -97.28% 52.21M -93.71% 68.96M -- 69.82M
Total assets less total liabilities
509.61% 1.72B 203.35% 1.81B 129.74% 281.34M -- 307M
Total equity and non-current liabilities
516.96% 1.74B 1522.33% 1.81B 185.06% 282.12M -- 307.96M
Equity
Share capital
36.76% 273.53M 2241.83% 273.53M -- 200M -- 200M
Reserve
1672.84% 1.44B 187.36% 1.54B 108.56% 81.34M -- 107M
Legal reserve
1672.84% 1.44B 187.36% 1.54B 108.56% 81.34M -- 107M
Shareholders' Equity
509.76% 1.72B 203.61% 1.81B 129.97% 281.34M -- 307M
Non-controlling interest
-- -427K -- -- -- -- -- --
Total equity
509.61% 1.72B 203.35% 1.81B 129.74% 281.34M -- 307M
Total equity and total liabilities
414.1% 1.8B 980.63% 1.86B 131.79% 350.3M -- 376.83M
Currency Unit
CNYCNYCNYCNY
Accounting Standards
IASIASIASIAS
Audit Opinions
Unqualified Opinion--Unqualified Opinion--
Auditor
KPMG accounting firm--KPMG accounting firm--

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%